
Custom acrylic celebrating a licensing agreement between Boehringer Ingelheim and Click Therapeutics. The agreement centers on a digital therapeutic for schizophrenia. (22AKL597)

Custom acrylic celebrating a licensing agreement between Boehringer Ingelheim and Click Therapeutics. The agreement centers on a digital therapeutic for schizophrenia. (22AKL597)
"*" indicates required fields